Thrice-daily biphasic insulin aspart 30 is more effective and as safe as a twice-daily regimen in subjects with type 2 diabetes inadequately controlled with OADs
第一作者机构：[1]China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China[2]Xijing Hosp, Dept Endocrinol, Xian, Peoples R China[3]Nanjing Drum Tower Hosp, Dept Endocrinol, Nanjing, Peoples R China[4]Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China[5]Wuhan Union Hosp, Dept Endocrinol, Wuhan, Peoples R China[6]Shanghai Changzheng Hosp, Dept Endocrinol, Tianjin, Peoples R China[7]Metab Dis Hosp, Dept Endocrinol, Tianjin, Peoples R China[8]Sun Yixian Commemorat Hosp, Dept Endocrinol, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714)：
Yang W.,Ji Q.,Zhu D.,et al.Thrice-daily biphasic insulin aspart 30 is more effective and as safe as a twice-daily regimen in subjects with type 2 diabetes inadequately controlled with OADs[J].DIABETOLOGIA.2007,50:S409-S409.
APA：
Yang, W.,Ji, Q.,Zhu, D.,Yang, J.,Chen, L....&Yan, L..(2007).Thrice-daily biphasic insulin aspart 30 is more effective and as safe as a twice-daily regimen in subjects with type 2 diabetes inadequately controlled with OADs.DIABETOLOGIA,50,
MLA：
Yang, W.,et al."Thrice-daily biphasic insulin aspart 30 is more effective and as safe as a twice-daily regimen in subjects with type 2 diabetes inadequately controlled with OADs".DIABETOLOGIA 50.(2007):S409-S409
医学